A partnership of highly experienced medicinal and computational chemists working at the cutting edge of modern drug design
We have more than 80 years of collective experience within drug discovery


We work with large pharma, small biotech, VC investors, academics and not-for-profit organisations to deliver novel hits, leads and preclinical candidate molecules and identify opportunities for in-licensing and out-licensing

Our Services

What Makes Us Unique

Our experienced team has a proven track record for delivery at all stages of small-molecule drug discovery across multiple disease areas, target classes and delivery modalities. Our team-based approach, in close partnership with our clients, maximises the chances of a successful project outcome.